CD22+ Relapsed/Refractory B-ALL

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB18801Yttrium Y-90 epratuzumab tetraxetan2Withdrawn1